In early CRC lesions, ablation of IL-17 signaling resulted in increased recruitment of CD4+ T cells to the tumors and elevated numbers of IL-10+ CD4+ T cells that are either Foxp3+ (Tregs) or Foxp3− (Tr1 cells) (Fig. 1d, e). This evidence concerns the gene FOXP3 and colorectal carcinoma.